An Open Label Multicenter Extension Study to Determine Long Term Safety and Efficacy of Pregabalin (Lyrica) as Monotherapy in Patients with Partial Seizures

Grants and Contracts Details

StatusFinished
Effective start/end date8/1/081/31/14

Funding

  • Pfizer Inc.: $22,354.00